IL166535A0 - Modified adamts4 molecules and method of use thereof - Google Patents

Modified adamts4 molecules and method of use thereof

Info

Publication number
IL166535A0
IL166535A0 IL16653505A IL16653505A IL166535A0 IL 166535 A0 IL166535 A0 IL 166535A0 IL 16653505 A IL16653505 A IL 16653505A IL 16653505 A IL16653505 A IL 16653505A IL 166535 A0 IL166535 A0 IL 166535A0
Authority
IL
Israel
Prior art keywords
molecules
modified adamts4
adamts4
modified
adamts4 molecules
Prior art date
Application number
IL16653505A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL166535A0 publication Critical patent/IL166535A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL16653505A 2002-07-29 2005-01-27 Modified adamts4 molecules and method of use thereof IL166535A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39872102P 2002-07-29 2002-07-29
PCT/US2003/023484 WO2004011637A2 (en) 2002-07-29 2003-07-29 Modified adamts4 molecules and method of use thereof

Publications (1)

Publication Number Publication Date
IL166535A0 true IL166535A0 (en) 2006-01-15

Family

ID=31188463

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16653505A IL166535A0 (en) 2002-07-29 2005-01-27 Modified adamts4 molecules and method of use thereof

Country Status (10)

Country Link
US (2) US7118902B2 (enExample)
EP (1) EP1525307A2 (enExample)
JP (1) JP2005534308A (enExample)
CN (1) CN1681920A (enExample)
AU (1) AU2003261269A1 (enExample)
BR (1) BR0313083A (enExample)
CA (1) CA2492444A1 (enExample)
IL (1) IL166535A0 (enExample)
MX (1) MXPA05000959A (enExample)
WO (1) WO2004011637A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4252892B2 (ja) 2001-06-01 2009-04-08 三菱製紙株式会社 全熱交換素子用紙
JP2005516614A (ja) 2002-02-05 2005-06-09 ワイス 切断アグレカナーゼ分子
CN1681920A (zh) * 2002-07-29 2005-10-12 惠氏公司 修饰的admts4分子及其使用方法
US7696307B2 (en) * 2004-04-12 2010-04-13 The Trustees Of The University Of Pennsylvania Function and regulation of ADAMTS-1
JP2007535920A (ja) * 2004-04-16 2007-12-13 ワイス トランケート型ａｄａｍｔｓ分子
WO2007025248A2 (en) * 2005-08-25 2007-03-01 Wyeth Aggrecanase structure
US7625731B2 (en) 2005-08-25 2009-12-01 Wyeth Aggrecanase structure
GB0601976D0 (en) * 2006-02-01 2006-03-15 Merck Sharp & Dohme Proteins
US20100062431A1 (en) * 2006-05-18 2010-03-11 Sanofi-Aventis Use of adamts4 gene and protein polymorphisms
US8263072B2 (en) * 2007-06-22 2012-09-11 Genera Istrazivanja, d.o.o. ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure
JP5341756B2 (ja) * 2007-06-29 2013-11-13 国立大学法人名古屋大学 神経障害に基づく機能不全の改善剤およびＲｈｏキナーゼ活性化抑制剤
EP2420250A1 (en) 2010-08-13 2012-02-22 Universitätsklinikum Münster Anti-Syndecan-4 antibodies
CA2927525C (en) 2013-10-15 2023-01-31 Genefrontier Corporation Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451575A (en) * 1967-09-15 1969-06-24 Geza Petro Jr Conveyor bucket with hydraulically-operated grille-like lid
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
ES8701226A1 (es) 1984-07-06 1986-11-16 Sandoz Ag Procedimiento de obtencion de una proteina de factor estimu-lante de colonias (csf) en primates
EP0177343B1 (en) 1984-10-05 1992-07-22 Genentech, Inc. Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery
US6069229A (en) * 1997-03-07 2000-05-30 Schering Corporation Mammalian proteinases; oxidoreductases; related reagents
AU8513198A (en) * 1997-07-25 1999-02-16 Du Pont Pharmaceuticals Company Aggrecan degrading metallo proteases
US6842704B2 (en) * 1998-02-04 2005-01-11 Immunex Corporation Crystalline TNF-α-converting enzyme and uses thereof
WO2000053774A2 (en) * 1999-03-08 2000-09-14 Neurocrine Biosciences, Inc. Metalloproteinases and methods of use therefor
US6391610B1 (en) * 1999-08-06 2002-05-21 The Cleveland Clinic Foundation Nucleic acids encoding zinc metalloproteases
EP1136547A3 (en) * 2000-03-22 2002-09-25 Pfizer Products Inc. Adamts polypeptides, nucleic acids encoding them, and uses thereof
US6458552B1 (en) * 2000-06-06 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Metalloprotease peptide substrates and methods
US20020151702A1 (en) * 2000-10-18 2002-10-17 Genetics Institute, Inc. Aggrecanase molecules
SE0102298D0 (sv) * 2001-06-27 2001-06-27 Astrazeneca Ab Crystal structure of enzyme and uses thereof
US20030148306A1 (en) * 2001-07-05 2003-08-07 Agostino Michael J. Aggrecanase molecules
WO2003016492A2 (en) * 2001-08-16 2003-02-27 The Regents Of The University Of Michigan Adamts13 genes and proteins and variants, and uses thereof
US20030105313A1 (en) * 2001-10-16 2003-06-05 American Home Products Corporation Aggrecanase molecules
JP2005515779A (ja) * 2002-01-31 2005-06-02 ワイス アグレカナーゼ分子
JP2005516614A (ja) * 2002-02-05 2005-06-09 ワイス 切断アグレカナーゼ分子
CN1681920A (zh) * 2002-07-29 2005-10-12 惠氏公司 修饰的admts4分子及其使用方法

Also Published As

Publication number Publication date
BR0313083A (pt) 2007-07-17
CN1681920A (zh) 2005-10-12
EP1525307A2 (en) 2005-04-27
US20060228354A1 (en) 2006-10-12
MXPA05000959A (es) 2005-05-16
US20040142863A1 (en) 2004-07-22
AU2003261269A1 (en) 2004-02-16
CA2492444A1 (en) 2004-02-05
WO2004011637A2 (en) 2004-02-05
WO2004011637A3 (en) 2004-04-08
JP2005534308A (ja) 2005-11-17
US7118902B2 (en) 2006-10-10

Similar Documents

Publication Publication Date Title
AU2003288902A8 (en) Microcapsules and methods of use
AU2003303128A8 (en) Inhibitors and methods of use thereof
EP1549614A4 (en) VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
AU2003278832A8 (en) Optical biosensors and methods of use thereof
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
EP1507756A4 (en) CCR9 INHIBITORS AND USE THEREOF
PL375052A1 (en) Pharmaceutical pig and method of use
AU2003231048A8 (en) Transposon system and methods of use
IL157142A0 (en) Modified antibodies and methods of use
GB0418969D0 (en) System of benchmarking and method thereof
AU2003259717A8 (en) Modulators of rabggt and methods of use thereof
AU2003269444A8 (en) An improved pacifier and method of use thereof
AU2003277259A8 (en) Immunoassay and method of use
AU2003247276A8 (en) Methods and apparatuses for characterizing stability of biological molecules
GB0325726D0 (en) System and method of facilitating appliance behavior modification
AU2003291399A8 (en) Methods for identifying risk of melanoma and treatments thereof
AU2003301883A8 (en) Modified luciferase nucleic acids and methods of use
GB2388734B (en) Method and apparatus to enhance the security of data
AU2003257126A8 (en) Method of producing non-recombinant bmp-2 and use thereof
AU2003267278A8 (en) Sensor assemblies and methods of securing elongated members within such assemblies
AU2003275056A8 (en) Novel lapacho compounds and methods of use thereof
GB2401094B (en) Labels and methods of manufacture thereof
EP1463828A4 (en) METHOD OF DETECTING AND DIGITIZING BACTERIA
AU2002363938A8 (en) Methods and use of motoneuronotropic factors